Clinical trial
Individually Adapted Therapy of Alcoholism
NCT00317031 · Central Institute of Mental Health, Mannheim, Other · Completed
Key facts
| NCT number | NCT00317031 |
|---|---|
| Title | Individually Adapted Therapy of Alcoholism |
| Official title | Individually Adapted Therapy of Alcoholism: Clinical Studies |
| Lead sponsor | Central Institute of Mental Health, Mannheim, Other |
| Collaborators | German Federal Ministry of Education and Research Merck Sharp & Dohme LLC Industry Dupont Applied Biosciences |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | Acamprosate or Naltrexone |
| Enrollment | 435 |
| Start date | Nov 1, 2002 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 21, 2006 |
| Last update posted | Jun 27, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: